STC1 and neoplasm: Ovarian cancer cells treated with a neutralizing anti-STC-1 monoclonal antibody exhibit higher apoptosis rates than control cells.207 In a mouse model of human lung cancer, targeting STC-1-expressed tumor cells exhibits efficient antitumor effects.208